WO2003029431A3 - Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus - Google Patents

Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus Download PDF

Info

Publication number
WO2003029431A3
WO2003029431A3 PCT/US2002/031655 US0231655W WO03029431A3 WO 2003029431 A3 WO2003029431 A3 WO 2003029431A3 US 0231655 W US0231655 W US 0231655W WO 03029431 A3 WO03029431 A3 WO 03029431A3
Authority
WO
WIPO (PCT)
Prior art keywords
nanoscaling
ordering
genetically engineered
hybrid materials
virus
Prior art date
Application number
PCT/US2002/031655
Other languages
French (fr)
Other versions
WO2003029431A2 (en
Inventor
Angela M Belcher
Seung-Wuk Lee
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Priority to EP02795498A priority Critical patent/EP1488010A4/en
Priority to JP2003532649A priority patent/JP4601292B2/en
Priority to KR10-2004-7004820A priority patent/KR20040037230A/en
Priority to CA 2462766 priority patent/CA2462766A1/en
Publication of WO2003029431A2 publication Critical patent/WO2003029431A2/en
Publication of WO2003029431A3 publication Critical patent/WO2003029431A3/en

Links

Classifications

    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L29/00—Semiconductor devices adapted for rectifying, amplifying, oscillating or switching, or capacitors or resistors with at least one potential-jump barrier or surface barrier, e.g. PN junction depletion layer or carrier concentration layer; Details of semiconductor bodies or of electrodes thereof  ; Multistep manufacturing processes therefor
    • H01L29/02—Semiconductor bodies ; Multistep manufacturing processes therefor
    • H01L29/04—Semiconductor bodies ; Multistep manufacturing processes therefor characterised by their crystalline structure, e.g. polycrystalline, cubic or particular orientation of crystalline planes
    • H01L29/045—Semiconductor bodies ; Multistep manufacturing processes therefor characterised by their crystalline structure, e.g. polycrystalline, cubic or particular orientation of crystalline planes by their particular orientation of crystalline planes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/54—Organic compounds
    • C30B29/58—Macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
    • C30B7/005—Epitaxial layer growth
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/588—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with semiconductor nanocrystal label, e.g. quantum dots
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L21/00—Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
    • H01L21/02—Manufacture or treatment of semiconductor devices or of parts thereof
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K71/00—Manufacture or treatment specially adapted for the organic devices covered by this subclass
    • H10K71/10—Deposition of organic active material
    • H10K71/191—Deposition of organic active material characterised by provisions for the orientation or alignment of the layer to be deposited
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/761—Biomolecules or bio-macromolecules, e.g. proteins, chlorophyl, lipids or enzymes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]

Abstract

The present invention includes methods for producing nanocrystals of semiconductor material that have specific crystallographic features such as phase and alignment by using a self-assembling biological molecule that has been modified to possess an amino acid oligomer that is capable of specific binding to semi-conductor material. One form of the present invention is a method to construct ordered nanoparticles within the liquid crystal of the self-assembling biological molecule.
PCT/US2002/031655 2001-10-02 2002-10-02 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus WO2003029431A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP02795498A EP1488010A4 (en) 2001-10-02 2002-10-02 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
JP2003532649A JP4601292B2 (en) 2001-10-02 2002-10-02 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale viruses
KR10-2004-7004820A KR20040037230A (en) 2001-10-02 2002-10-02 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
CA 2462766 CA2462766A1 (en) 2001-10-02 2002-10-02 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32658301P 2001-10-02 2001-10-02
US60/326,583 2001-10-02

Publications (2)

Publication Number Publication Date
WO2003029431A2 WO2003029431A2 (en) 2003-04-10
WO2003029431A3 true WO2003029431A3 (en) 2004-10-07

Family

ID=23272834

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/031655 WO2003029431A2 (en) 2001-10-02 2002-10-02 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus

Country Status (8)

Country Link
US (3) US20030073104A1 (en)
EP (1) EP1488010A4 (en)
JP (1) JP4601292B2 (en)
KR (1) KR20040037230A (en)
CN (2) CN1697884A (en)
AU (1) AU2008221594A1 (en)
CA (1) CA2462766A1 (en)
WO (1) WO2003029431A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030148380A1 (en) * 2001-06-05 2003-08-07 Belcher Angela M. Molecular recognition of materials
US20030113714A1 (en) * 2001-09-28 2003-06-19 Belcher Angela M. Biological control of nanoparticles
US20050164515A9 (en) * 2001-06-05 2005-07-28 Belcher Angela M. Biological control of nanoparticle nucleation, shape and crystal phase
US8865347B2 (en) * 2001-09-28 2014-10-21 Siluria Technologies, Inc. Digital alloys and methods for forming the same
US20030073104A1 (en) * 2001-10-02 2003-04-17 Belcher Angela M. Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
WO2003078451A2 (en) * 2002-03-13 2003-09-25 New Century Pharmaceuticals, Inc. Method of isolating binding peptides from a combinatorial phage display library and peptides produced thereby
JP2006517186A (en) * 2002-09-04 2006-07-20 ボード オブ リージェンツ ユニバーシティ オブ テキサス システム Bifunctional biomaterial compositions, methods, and uses
US20050064508A1 (en) 2003-09-22 2005-03-24 Semzyme Peptide mediated synthesis of metallic and magnetic materials
AU2003298587A1 (en) * 2002-09-18 2004-05-04 Board Of Regents, University Of Texas System Peptide mediated synthesis of metallic and magnetic materials
AU2003298590B2 (en) * 2002-09-24 2009-11-19 Board Of Regents, University Of Texas System Fabricated biofilm storage device
US20040171139A1 (en) * 2002-09-24 2004-09-02 Belcher Angela M. Fabricated biofilm storage device
US7498403B2 (en) 2003-07-30 2009-03-03 Japan Science And Technology Agency Peptides capable of binding to titanium silver silicone
EP1682568A4 (en) * 2003-10-15 2009-10-28 Univ Texas Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications
AU2004282563A1 (en) * 2003-10-15 2005-04-28 Board Of Regents, The University Of Texas System Viral fibers
US7923109B2 (en) * 2004-01-05 2011-04-12 Board Of Regents, The University Of Texas System Inorganic nanowires
EP1725112A4 (en) * 2004-02-05 2007-10-24 Massachusetts Inst Technology Cell display libraries
EP1732952A2 (en) 2004-03-31 2006-12-20 Canon Kabushiki Kaisha Gold-binding protein and use thereof
WO2006076027A2 (en) * 2004-05-17 2006-07-20 Cambrios Technology Corp. Biofabrication of transistors including field effect transistors
US20070178658A1 (en) * 2004-06-21 2007-08-02 Kelley Tommie W Patterning and aligning semiconducting nanoparticles
KR20070091608A (en) 2004-10-19 2007-09-11 매사추세츠 인스티튜트 오브 테크놀로지 Biomolecular recognition of crystal defects
WO2006060171A2 (en) * 2004-11-16 2006-06-08 Board Of Regents, The University Of Texas System Methods and compositions related to phage-nanoparticle assemblies
US7695981B2 (en) * 2005-05-13 2010-04-13 Siluria Technologies, Inc. Seed layers, cap layers, and thin films and methods of making thereof
US7902639B2 (en) * 2005-05-13 2011-03-08 Siluria Technologies, Inc. Printable electric circuits, electronic components and method of forming the same
US9274108B2 (en) * 2006-02-06 2016-03-01 Massachusetts Institute Of Technology Self-assembly of macromolecules on multilayered polymer surfaces
US7960721B2 (en) * 2006-05-19 2011-06-14 Siluria Technologies, Inc. Light emitting devices made by bio-fabrication
US7393699B2 (en) 2006-06-12 2008-07-01 Tran Bao Q NANO-electronics
JP5300205B2 (en) * 2007-03-22 2013-09-25 キヤノン株式会社 Target substance detection element, target substance detection method, and method for manufacturing target substance detection element

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010008759A1 (en) * 1998-04-24 2001-07-19 James D. Marks Methods of selecting internalizing antibodies
US6329209B1 (en) * 1998-07-14 2001-12-11 Zyomyx, Incorporated Arrays of protein-capture agents and methods of use thereof
US20020107179A1 (en) * 2000-03-06 2002-08-08 Potts Steven J. Detection and removal of microorganism contamination

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593002A (en) * 1982-01-11 1986-06-03 Salk Institute Biotechnology/Industrial Associates, Inc. Viruses with recombinant surface proteins
CH0229046H1 (en) * 1985-03-30 1998-07-15 Stuart Alan Kauffman METHOD FOR OBTAINING DNA, RNA, PEPTIDES, POLYPEPTINIQUE. DES OR PROTEINS BY MEANS OF A DNA RECOMBINANT TECH
US5866363A (en) * 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
US5763192A (en) * 1986-11-20 1998-06-09 Ixsys, Incorporated Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5683867A (en) * 1990-06-11 1997-11-04 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: blended SELEX
US5650489A (en) * 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
US5264563A (en) * 1990-08-24 1993-11-23 Ixsys Inc. Process for synthesizing oligonucleotides with random codons
CA2095633C (en) * 1990-12-03 2003-02-04 Lisa J. Garrard Enrichment method for variant proteins with altered binding properties
US5270170A (en) * 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
JPH07502479A (en) * 1991-11-22 1995-03-16 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Semiconductor microcrystals covalently bonded to solid inorganic surfaces using self-assembled monolayers
US5316922A (en) * 1992-04-15 1994-05-31 The United States Of America As Represented By Department Of Health And Human Services Method for indentifying and expressing proteins that recognize and adhere to specific probes
CH685003A5 (en) * 1992-08-11 1995-02-28 Buehler Ag A method of continuously crystallizing and polymerizing plastic material, and apparatus therefor.
US5417340A (en) * 1993-06-01 1995-05-23 Hubbell Incorporated Spring-biased floating hinge structure
CA2179315A1 (en) * 1993-12-17 1995-06-22 Roger S. Cubicciotti Nucleotide-directed assembly of bimolecular and multimolecular drugs and devices
US5744627A (en) * 1994-01-28 1998-04-28 Prolinx, Inc. Boronic compound complexing reagents and complexes
US5714330A (en) * 1994-04-04 1998-02-03 Lynx Therapeutics, Inc. DNA sequencing by stepwise ligation and cleavage
US5506420A (en) * 1994-09-14 1996-04-09 The Regents Of The University Of California Semiconductor bio-electronic devices incorporating biochemical stabilization layers
US5985353A (en) * 1994-12-01 1999-11-16 University Of Massachusetts Lowell Biomolecular synthesis of quantum dot composites
US6699658B1 (en) * 1996-05-31 2004-03-02 Board Of Trustees Of The University Of Illinois Yeast cell surface display of proteins and uses thereof
US6017390A (en) * 1996-07-24 2000-01-25 The Regents Of The University Of California Growth of oriented crystals at polymerized membranes
US6361944B1 (en) * 1996-07-29 2002-03-26 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
US6025485A (en) * 1997-02-14 2000-02-15 Arcaris, Inc. Methods and compositions for peptide libraries displayed on light-emitting scaffolds
DE19711484C1 (en) * 1997-03-19 1998-09-03 Siemens Ag Computerised optimised imaging by modelling software
US20020114987A1 (en) * 1997-09-24 2002-08-22 Sven Oscarsson Method of arraying nanoparticles and macromolecules on surfaces
US6207392B1 (en) * 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
US5990479A (en) * 1997-11-25 1999-11-23 Regents Of The University Of California Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6100035A (en) * 1998-07-14 2000-08-08 Cistem Molecular Corporation Method of identifying cis acting nucleic acid elements
US6235540B1 (en) * 1999-03-30 2001-05-22 Coulter International Corp. Semiconductor nanoparticles for analysis of blood cell populations and methods of making same
US6472147B1 (en) * 1999-05-25 2002-10-29 The Scripps Research Institute Methods for display of heterodimeric proteins on filamentous phage using pVII and pIX, compositions, vectors and combinatorial libraries
US20030148380A1 (en) * 2001-06-05 2003-08-07 Belcher Angela M. Molecular recognition of materials
US20030113714A1 (en) * 2001-09-28 2003-06-19 Belcher Angela M. Biological control of nanoparticles
US20050164515A9 (en) * 2001-06-05 2005-07-28 Belcher Angela M. Biological control of nanoparticle nucleation, shape and crystal phase
US20030073104A1 (en) * 2001-10-02 2003-04-17 Belcher Angela M. Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010008759A1 (en) * 1998-04-24 2001-07-19 James D. Marks Methods of selecting internalizing antibodies
US6329209B1 (en) * 1998-07-14 2001-12-11 Zyomyx, Incorporated Arrays of protein-capture agents and methods of use thereof
US20020107179A1 (en) * 2000-03-06 2002-08-08 Potts Steven J. Detection and removal of microorganism contamination

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE CA 2002, NIIKURA K.: "Ordening of inorganic nanocrystals using viruses", XP002978456 *
KAGAKU TO KOGYO, vol. 55, no. 2, 2002, TOKYO, JAPAN, pages 1363 *
WHALEY S.R.: "Borrowing ideas from nature: peptide-specific bidning to gallium arsenide", MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS, vol. 599, 2000, pages 189 - 199, XP002978284 *
WHALEY S.R.: "Selection of peptides with semiconductor binding specificity for directed nanocrystal assembly", NATURE, vol. 405, no. 6787, 2000, LONDON, pages 665 - 668, XP002909553 *

Also Published As

Publication number Publication date
EP1488010A4 (en) 2007-04-25
JP4601292B2 (en) 2010-12-22
AU2008221594A1 (en) 2008-10-16
CN101694832A (en) 2010-04-14
US20080206838A1 (en) 2008-08-28
KR20040037230A (en) 2004-05-04
CN1697884A (en) 2005-11-16
JP2005508163A (en) 2005-03-31
US20030073104A1 (en) 2003-04-17
CA2462766A1 (en) 2003-04-10
EP1488010A2 (en) 2004-12-22
WO2003029431A2 (en) 2003-04-10
US20110300605A1 (en) 2011-12-08

Similar Documents

Publication Publication Date Title
WO2003029431A3 (en) Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
Hecht et al. SrAlSi4N7: Eu2+− A nitridoalumosilicate phosphor for warm white light (pc) LEDs with edge-sharing tetrahedra
KR100978490B1 (en) Uniformly b-Oriented MFI Zeolite Films with Variable Thicknesses Supported on Substrates and the Preparation Method Thereof
Moore et al. Growth of anisotropic one-dimensional ZnS nanostructures
Li et al. Synthesis of a multinary nitride, Eu-doped CaAlSiN3, from alloy at low temperatures
US7153703B2 (en) Synthesis of stable colloidal nanocrystals using organic dendrons
JP2020041151A (en) Luminescent crystals and manufacturing thereof
Lee et al. Biomimetic and aggregation-driven crystallization route for room-temperature material synthesis: growth of β-Ga2O3 nanoparticles on peptide assemblies as nanoreactors
Berrocal et al. Unraveling the driving forces in the self-assembly of monodisperse naphthalenediimide-oligodimethylsiloxane block molecules
WO2003048225A3 (en) Process for producing aryl-aryl coupled compounds
US20150274895A1 (en) Highly Refractive Surface Treatment Agent, And Fine Member And Optical Material Surface-Treated Using The Same
Cheng et al. Self-assembled growth and pore size control of the bubble-template porous carbonated hydroxyapatite microsphere
JP2005298319A5 (en)
WO2004033488A3 (en) Peptide mediated synthesis of metallic and magnetic materials
DE60235306D1 (en) METHOD FOR THE PRODUCTION OF COLLOIDAL NANOCLIST
EP3805248A3 (en) Process for concentration of antibodies and therapeutic products thereof
Murai et al. Mineralization of calcium carbonate on multifunctional peptide assembly acting as mineral source supplier and template
WO2007075886A3 (en) Non-spherical semiconductor nanocrystals and methods of making them
Ikigaki et al. Epitaxial Growth of Multilayered Metal–Organic Framework Thin Films for Electronic and Photonic Applications
Creff et al. Self-assembly of bridged silsesquioxanes: modulating structural evolution via cooperative covalent and noncovalent interactions
TW201840722A (en) Phosphor sheet, led chip using same, led package using same, method for producing led package, and light emitting device, backlight unit and display, each of which comprises said led package
Chen et al. Self-assembly of cyclic dipeptides: Platforms for functional materials
Suckert et al. Efficient strain-induced light emission in lonsdaleite germanium
EP1281420A3 (en) Crystallisation process using ultrasound
DE60335616D1 (en) METHOD FOR PRODUCING SILICON INCLUDED CRYSTALS, AND PRODUCED THEREFORE BY SILICON CRYSTAL WAFERS AND SILICON INCRACIAL STAINS

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1020047004820

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2462766

Country of ref document: CA

Ref document number: 20028195655

Country of ref document: CN

Ref document number: 2003532649

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002360254

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2002795498

Country of ref document: EP

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWP Wipo information: published in national office

Ref document number: 2002795498

Country of ref document: EP